Endometrial abnormalities in breast cancer patients with tamoxifen therapy

Autor: Constantin Prevedourakis, Antonios Xygakis, Stelios Michalas, Marios Dachlythras, Nikolas Makris
Rok vydání: 2000
Předmět:
Zdroj: Gynaecological Endoscopy. 9:23-26
ISSN: 0962-1091
DOI: 10.1046/j.1365-2508.2000.00301.x
Popis: Objective Evaluation of the effect of tamoxifen therapy on endometrium in patients who have previously undergone surgery for breast cancer. Design An analysis of hysteroscopic findings and their correlation with those from previous vaginal ultrasonography and subsequent endometrial sampling. Setting The hysteroscopy unit of a university clinic. Subjects 64 patients referred from the breast clinic, who had previously undergone surgery for breast cancer and who were receiving adjuvant tamoxifen therapy, with either suspicious findings on routine vaginal ultrasonography or abnormal uterine bleeding. Of the patients, 22 were premenopausal (group A) and 42 postmenopausal (group B). Each group was divided in two subgroups, comprising either symptomatic patients (groups A1 and B1) or asymptomatic patients (groups A2 and B2). Intervention: Diagnostic hysteroscopy. Results All six patients of group A1 were found to have hyperplastic endometrium on hysteroscopy. Subsequent biopsy after dilation and curettage (DC there was one polyp, and three cases of hyperplastic endometrium, which were found to be simple hyperplasia on pathological investigation. Conclusions Monitoring of the uterine cavity in patients receiving tamoxifen therapy is mandatory, especially where there is postmenopausal bleeding. Hysteroscopy findings display a considerably higher degree of correlation with endometrial pathology results, than do vaginal ultrasonography findings.
Databáze: OpenAIRE